Genetic Testing
Genetic Testing is an intervention with 56 clinical trials. Currently 28 active trials ongoing. Historical success rate of 88.9%.
Success Metrics
Based on 16 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
2
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
88.9%
16 of 18 finished
11.1%
2 ended early
28
trials recruiting
56
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Family Communications After Genetic Testing
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD)
Clinical Trials (56)
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Family Communications After Genetic Testing
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD)
Evaluating the Prevalence of Acute Hepatic Porphyria in Postural Tachycardia Syndrome
Decision Support Tool to Enhance Germline Genetic Testing for Patients With Prostate Cancer
Genetic Testing in Predicting Tumor Response in Patients With Stage I-III HER2 Negative Invasive Breast Cancer
Using Tumour DNA and Proteins to Better Understand How Pancreatic Cancer Responds to Treatment
Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
Molecular Basis of Langerhans and Non-Langerhans Cell Histiocytic Neoplasms and Castleman Disease
Natural History Study of and Genetic Modifiers in Spinocerebellar Ataxias
Investigation of Tumour Spectrum of Germline Mutations in Breast and Ovarian Cancer Genes.
Genetic Testing for the Prevention of Cancer in American Indian Communities (JUNIPER Trial)
Genetic Information to Inform Treatment and Screening for Prostate Cancer, GIFTS Study
Identifying and Caring for Individuals With Inherited Cancer Syndrome
Neural-Derived Plasma Exosomal MicroRNAs As Promising Novel Biomarkers for Suicidality and Treatment Outcome in Adolescents
TSC Biosample Repository and Natural History Database
Genes Associated With Development of Pulmonary Arterial Hypertension in Patients With Congenital Shunt Lesions
Genotype Guided Antiplatelet Therapy In Ischemic Stroke
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 56